Highest-materiality recent filing
Gencor regains NYSE American listing compliance after filing delayed Q1 10-Q
Filed Form 10-Q for quarter ended March 31, 2026 on June 12, 2026, curing the delinquency.
Gencor Q2 net income down 37% to $0.26 EPS; backlog doubles to $60.5M
Net revenue $33.8M vs $38.2M a year ago; net income $3.8M vs $6.1M ($0.26 vs $0.42 EPS).
Gencor appoints Raymond Cole as Interim CFO
Raymond Cole appointed Interim CFO effective June 1, 2026.
Gencor receives NYSE American delinquency notice for late Q2 2026 10-Q filing
Received delinquency notice from NYSE American on May 19, 2026 for failure to timely file Q2 2026 10-Q (due May 18, 2026).
Gencor Industries CFO Eric Mellen to retire effective June 10, 2026
CFO and Treasurer Eric Mellen notified the company of his retirement on May 14, 2026.
E.J. Elliott gifted his LLC membership interests to Marc G. Elliott on May 1, 2026, transferring control.
Gencor Industries annual meeting elects directors, ratifies auditor, approves 3-year say-on-pay
John G. Coburn elected Common Stock director with 5.45M votes for, 3.70M withheld, 1.37M broker non-votes.
Gencor Q1 revenue falls 25% to $23.6M; EPS $0.23 vs $0.26; backlog rises
Net revenue $23.6M, down 25% from $31.4M YoY; operating income $3.1M vs $4.6M.
Board dismissed BPB and appointed CRI effective Jan 27, 2026, following CRI's asset acquisition of BPB's capital markets practice on Jan 1, 2026.
Gencor sets 2026 annual meeting for April 3; proposal deadline February 2
Annual meeting scheduled for April 3, 2026; record date February 26, 2026.
Gencor founder EJ Elliott retiring Dec 31; Marc Elliott named Chairman
Executive Chairman EJ Elliott, founder in 1968, retires effective December 31, 2025.
Gencor FY2025 EPS $1.07, up 8% YoY; Q4 revenue down 10%
FY2025 net revenue $115.4M (+2% YoY); net income $15.66M ($1.07 diluted EPS) vs $14.56M ($0.99).
Annual meeting elects directors and ratifies auditor; no material changes
Directors elected: General John G. Coburn (Common Stock), E.J. Elliott, Marc G. Elliott, Thomas A. Vecchiolla, Walter A. Ketcham, Jr. (Class B).
Gencor Q3 revenue up 5.6% to $26.99M; EPS $0.26 vs $0.17
Revenue $26.99M (+5.6% YoY); gross margin improved to 26.5% from 23.9%.
Gencor regains NYSE American listing compliance after filing overdue reports
Filed delinquent 10-K on June 27, 2025 and two 10-Qs on July 25, 2025.
Gencor Q1 revenue up 20.7% to $31.4M; EPS falls to $0.26 on securities losses
Net income $3.8M ($0.26 EPS) vs $4.3M ($0.30) YoY; operating income rose to $4.6M from $3.4M.
Gencor Q2 fiscal 2025 revenue down 6.1%; EPS flat at $0.42; backlog falls to $27.8M
Net revenue $38.2M (-6.1% YoY); gross margin 29.7% vs 30.3%.
Gencor Industries schedules 2025 annual meeting for Sept 26, record date Aug 11
Annual Meeting set for September 26, 2025; record date for voting is August 11, 2025.
Gencor receives NYSE American extension to Aug 19, 2025 to file delinquent reports
NYSE accepted extension request; new cure deadline August 19, 2025.
Gencor reports FY2024 revenue up 7.7% to $113.2M; EPS $0.99 vs $1.00; backlog $56.2M
Full year net revenue $113.2M, up 7.7% from $105.1M; net income $14.6M ($0.99 diluted EPS) vs $14.7M ($1.00).
Gencor reports Q1 FY25 revenue ~$31M, up 20% YoY; cash & securities ~$144M
Revenue of ~$31M for Q1 FY25 ended Dec 31, 2024, vs $26M in Q1 FY24, up ~20%.
Gencor reports preliminary FY2024 revenue ~$113M, up 7.5% YoY; $130M cash, no debt
Revenue for FY ended Sep 30, 2024 ~$113M vs $105.1M in FY2023, up ~7.5% YoY.
Gencor Industries dismisses Forvis Mazars as auditor, cites material weaknesses in internal controls
Dismissed Forvis Mazars on Feb 13, 2025; no disagreements with Forvis Mazars during engagement.
Gencor receives NYSE American delinquency notice for late 10-K filing; six months to comply
NYSE American notified Gencor on Jan 3, 2025, that it failed to timely file Form 10-K for FY2024 by Dec 31, 2024 extension deadline.
Gencor appoints Forvis Mazars as auditor after MSL acquisition
On Nov 1, 2024, MSL was acquired by Forvis Mazars; Gencor's Board dismissed MSL and appointed Forvis Mazars.
Q3 net income down 20% to $2.56M; revenue falls 8% to $25.6M; backlog hits record $46.6M
Revenue $25.6M vs $27.9M YoY; gross margin down 300bps to 23.9%.
Gencor Q2 fiscal 2024 revenue up 33% to $40.7M; net income $6.2M ($0.42/share)
Net revenue $40.7M (+33.4% YoY); gross margin 30.3% vs 29.8%; operating income $7.1M (+37%).
Elected directors: General John G. Coburn (Common) with 4.68M votes; Class B seats unanimous for Elliott, Elliott, Vecchiolla, Ketcham.
Gencor Q1 net income $4.3M ($0.30/sh) vs $3.5M ($0.24/sh); gross margin improves to 29%
Net revenue $26.0M flat YoY; gross margin up to 29.0% (was 22.5%) on better manufacturing efficiencies.
Gencor reports FY2023 net income of $14.7M vs loss; backlog up to $57.8M
FY2023 revenue $105.1M (+1.5% YoY); net income $14.7M ($1.00 EPS) vs net loss $0.4M.
Gencor Q3 FY2023 net income $3.2M vs prior-year loss; gross margin improves to 26.9%
Net income $3.212M ($0.22 EPS) vs net loss $(1.015M) ($0.07 loss) in Q3 2022.
Gencor Q2 net income surges to $0.33/diluted from $0.03; gross margins up 960 bps
Net revenue $30.5M (flat YoY); gross margin 29.8% vs 20.2% on efficiency and pricing.
Gencor shareholders elect all director nominees, ratify auditor, approve say-on-pay
All four Class B director nominees (E.J. Elliott, Marc G. Elliott, Thomas A. Vecchiolla, Walter A. Ketcham, Jr.) elected with 2,318,857 votes each.
Gencor Q1 fiscal 2023 net income $3.5M vs loss; revenue up 28.4% to $25.8M
Net revenue $25.8M vs $20.1M YoY (+28.4%); gross margin improved to 22.5% from 18.4%.
Q4 revenue $23.1M (+15.5% YoY), gross margin 21.5% vs 17.2%.
Gencor Q3 net loss $1.0M ($0.07/share) on investment losses; revenue up 19% to $29.6M
Revenue $29.6M, up 19% YoY; gross margin fell to 19.2% from 22.5% on higher steel and labor costs.
Gencor Industries to transfer stock listing from NASDAQ to NYSE American effective August 1, 2022
Voluntary transfer of common stock listing from NASDAQ Global Market to NYSE American.
Gencor Q2 FY2022: revenue $30.7M (+43.6% YoY); net income drops to $0.4M from $2.3M
Revenue for quarter ended March 31, 2022: $30.7M vs $21.4M YoY; gross margin 20.2% vs 28.8%.
Gencor Industries announces annual meeting results: directors elected and auditors ratified
Shareholders elected General John G. Coburn (Ret.) as director for Common Stock; E.J. Elliott, Marc G. Elliott, Thomas A. Vecchiolla, Walter A. Ketcham Jr. for Class B Stock.
Gencor reports Q1 FY2022 net loss of $0.3M vs net income of $1.6M YoY; backlog rises to $58M
Net loss $274,000 ($0.02 per share) vs net income $1.5M ($0.11 per share) in prior year.
Q4 revenue surged 91.7% to $20.0M; Q4 net loss narrowed to ($0.4M) from ($0.6M).
Gencor Industries removes CEO John E. Elliott effective November 1, 2021
John E. Elliott removed as CEO by unanimous board vote on Nov 1, 2021.
GenCor Industries appoints Walter Ketcham to Board, effective Oct 28, 2021
Walter Ketcham appointed as Director, filling a vacancy on the Board, effective October 28, 2021.
Gencor Industries removes director James P. Sharp without cause
On October 20, 2021, Class B stockholders removed James P. Sharp as director without cause.
Net revenue $24.9M (+8.6% YoY); net income $2.3M vs $4.3M; diluted EPS $0.16 down from $0.29.
Gencor appoints Thomas Vecchiolla to Board, serving on Audit and Compensation committees
Thomas Vecchiolla appointed as Director effective July 12, 2021 to fill a vacancy on the Board.
On June 1, 2026, Gencor Industries, Inc. (the “Company”) appointed Mr. Raymond Cole as the Company’s Interim Chief Financial Officer.
On May 14, 2026, Eric Mellen, who serves as Chief Financial Officer and Treasurer of Gencor Industries, Inc. (the “Company”), provided notice of his decision to retire effective June 10, 2026.
John E. Elliott was removed as CEO of the Company.
The Board of Directors (the “Board”) has unanimously appointed Mr. Walter Ketcham as Director, effective October 28, 2021 to fill a vacancy on the Board.
On October 20, 2021, holders of Class B Stock of Gencor Industries, Inc. (the “Company”), by majority written consent, removed James P. Sharp, without cause, as a director from the Board of Directors of the Company (the “Board”).
The Board of Directors has appointed Mr. Thomas Vecchiolla as Director, effective July 12, 2021 to fill a vacancy on the Board.
Max materiality 0.85 · Median 0.60 · Most common event earnings